GPP
Great Point Partners’s CytomX Therapeutics CTMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,500,000
| Closed | -$7.64M | – | 39 |
|
|
2021
Q3 | $7.64M | Buy |
1,500,000
+500,000
| +50% | +$2.55M | 1.78% | 25 |
|
|
2021
Q2 | $6.33M | Buy |
+1,000,000
| New | +$6.33M | 1.33% | 26 |
|
|
2020
Q3 | – | Sell |
-1,448,604
| Closed | -$12.1M | – | 36 |
|
|
2020
Q2 | $12.1M | Buy |
1,448,604
+1,308,886
| +937% | +$10.9M | 0.96% | 25 |
|
|
2020
Q1 | $1.07M | Buy |
+139,718
| New | +$1.07M | 0.11% | 31 |
|
|
2019
Q2 | – | Sell |
-959,077
| Closed | -$10.3M | – | 28 |
|
|
2019
Q1 | $10.3M | Buy |
+959,077
| New | +$10.3M | 1.02% | 22 |
|